Literature DB >> 3535598

Bronchial and alveolar absorption of inhaled 99mTc-DTPA.

G Oberdörster, M J Utell, P E Morrow, R W Hyde, D A Weber.   

Abstract

The clearance rate of 99mTc-DTPA deposited in the lung by inhalation has been used as an index to measure lung epithelial permeability. To determine if differences exist between alveolar and bronchial absorption of 99mTc-DTPA we measured regional clearance rates in 4 beagle dogs for 30 min after preferential bronchial and alveolar deposition. Alveolar deposition was maximized by inhalation for 2 min of small 99mTc-DTPA particles (activity median aerodynamic diameter, AMAD = 0.5 micron; geometric standard deviation, GSD = 1.6) with deep slow ventilation (VT = 350 ml; f = 9 min-1), and bronchial deposition was increased by inhalation of large particles (AMAD = 4.1 microns, GSD = 2.3) with rapid shallow ventilation (VT = 50 ml; f = 65 min-1). Respective clearance rates from basal regions, which represent mainly alveolar absorption, were: for small particles, 2.29% min-1; for large particles, 1.57% min-1 (p = 0.10). Apical regions, which contain relatively more bronchial surface than do the basal regions, showed the following clearance rates: for small particles, 1.76% min-1; for large particles, 1.31% min-1 (p less than 0.05). These results indicate that in vivo alveolar absorption of 99mTc-DTPA is more rapid than bronchial absorption. Control or verification of the site of deposition of the tracer in the lung is of importance for the interpretation of the results of the 99mTc-DTPA lung permeability assay.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3535598     DOI: 10.1164/arrd.1986.134.5.944

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

1.  A pore transport model for pulmonary alveolar epithelium.

Authors:  T Chandra; I F Miller; D B Yeates
Journal:  Ann Biomed Eng       Date:  1992       Impact factor: 3.934

Review 2.  Pulmonary clearance of 99mTc-DTPA: a noninvasive assessment of epithelial integrity.

Authors:  H O'Brodovich; G Coates
Journal:  Lung       Date:  1987       Impact factor: 2.584

3.  Clearance of 99mTc DTPA from guinea pig nasal, tracheobronchial, and bronchoalveolar airways.

Authors:  L Greiff; P Wollmer; I Erjefält; U Pipkorn; C G Persson
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

4.  Binding and diffusion characteristics of 14C EDTA and 99mTc DTPA in respiratory tract mucus glycoprotein from patients with chronic bronchitis.

Authors:  M S Cheema; S Groth; C Marriott
Journal:  Thorax       Date:  1988-09       Impact factor: 9.139

5.  Absorption of intra-bronchial diprophylline-methodology and preliminary results.

Authors:  J A Morais; M C Neves; J R Silva; R Avila
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Jul-Sep       Impact factor: 2.441

6.  Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes.

Authors:  Kavitha Koushik; Devender S Dhanda; Narayan P S Cheruvu; Uday B Kompella
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

Review 7.  Aerosols for systemic treatment.

Authors:  D Köhler
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 8.  Pulmonary nuclear medicine.

Authors:  R F Miller; M J O'Doherty
Journal:  Eur J Nucl Med       Date:  1992

9.  Influence of hilar deposition in the evaluation of the alveolar epithelial permeability on 99mTc-DTPA aerosol inhaled scintigraphy.

Authors:  Shigeyuki Ogi; Eisuke Gotoh; Mayuki Uchiyama; Kunihiko Fukuda; Mitsuyoshi Urashima; Nobuyoshi Fukumitsu
Journal:  Jpn J Radiol       Date:  2009-02-08       Impact factor: 2.374

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.